CONSOLIDATED BALANCE SHEETS (unaudited) - USD ($) $ in Thousands		Mar. 31, 2018	Dec. 31, 2017
ASSETS
Cash and due from banks		$ 348,027	$ 397,848
Interest bearing funds with Federal Reserve Bank		636,947	460,928
Interest earning deposits with banks		16,851	26,311
Federal funds sold and securities purchased under resale agreements		57,192	47,846
Total cash, cash equivalents, restricted cash, and restricted cash equivalents	[1],[2]	1,059,017	932,933
Mortgage loans held for sale, at fair value		50,439	48,024
Investment securities available for sale, at fair value		3,990,978	3,987,069
Loans, net of deferred fees and costs		24,883,037	24,787,464
Allowance for loan losses		(257,764)	(249,268)
Loans, net		24,625,273	24,538,196
Cash surrender value of bank-owned life insurance		543,684	540,958
Premises and equipment, net		424,342	426,813
Goodwill		57,315	57,315
Other intangible assets		10,750	11,254
Deferred tax asset, net		179,343	165,788
Other assets		559,887	513,487
Total assets		31,501,028	31,221,837
Deposits:
Non-interest bearing deposits		7,381,070	7,686,339
Interest bearing deposits, excluding brokered deposits		16,865,859	16,500,436
Brokered deposits		2,006,578	1,961,125
Total deposits		26,253,507	26,147,900
Federal funds purchased and securities sold under repurchase agreements		185,531	161,190
Long-term debt		1,856,392	1,706,138
Other liabilities		249,103	245,043
Total liabilities		28,544,533	28,260,271
Shareholders' Equity
Series C Preferred Stock – no par value. Authorized 100,000,000 shares; 5,200,000 shares issued and outstanding at March 31, 2018 and December 31, 2017		125,980	125,980
Common stock - $1.00 par value. Authorized 342,857,143 shares; 143,017,301 issued at March 31, 2018 and 142,677,449 issued at December 31, 2017; 118,702,497 outstanding at March 31, 2018 and 118,897,295 outstanding at December 31, 2017		143,017	142,678
Additional paid-in capital		3,039,757	3,043,129
Treasury stock, at cost – 24,314,804 shares at March 31, 2018 and 23,780,154 shares at December 31, 2017		(866,407)	(839,674)
Accumulated other comprehensive loss		(107,777)	(54,754)
Retained earnings		621,925	544,207
Total shareholders’ equity		2,956,495	2,961,566
Total liabilities and shareholders' equity		$ 31,501,028	$ 31,221,837

[1] See "Note 1 - Significant Accounting Policies" of this Report for information on Synovus' change in presentation of cash and cash equivalents.

[2] See "Note 1 - Significant Accounting Policies" of this Report for information on Synovus' change in presentation of cash and cash equivalents.